November 1999
AIDS Patient Care & STDs;Nov99, Vol. 13 Issue 11, p681
Academic Journal
Reports the efficacy of atovaquone suspension in preventing pneumocystis carinii pneumonia in HIV-infected patients. Comparison to aerosolized pentamidine; Treatment in patients intolerant to trimethoprim/sulfonamides; Impact on incidence and mortality.


Related Articles

  • Further Promise with AIDS Drug. Helquist, Michael // Advocate;5/10/88, Issue 498, p38 

    Reports on clinical trials of Imreg-I, an anti-AIDS drug. Drug manufacturer Imreg Inc.'s refusal to release study results to the popular press; Ability of the drug to slow or to prevent the development of pneumocystis pneumonia; Stabilization of anemia common to HIV infection.

  • Pneumocystis carinii pneumonia.  // MMWR: Morbidity & Mortality Weekly Report;6/27/1997 Supplement RR-12, Vol. 46, p4 

    Provides information on the disease pneumocystis carinii pneumonia. Recommendation made by authorities relating to the prevention of exposure to disease; Precautions that should be considered by adolescents, adults and pregnant women.

  • DELAYING THE ONSET OF ILLNESS. Cohan, Gary R. // Advocate;2/8/94, Issue 648, p34 

    Reports that prophylaxis against Pneumocystis carinnii infection may delay the onset of the first AIDS-related illness.

  • Prophylaxis Failure Is Associated with a Specific Pneumocystis carinii Genotype. Hauser, Philippe M.; Sudre, Philippe; Nahimana, Aimable; Francioli, Patrick // Clinical Infectious Diseases;10/1/2001, Vol. 33 Issue 7, p1080 

    To investigate the possible association between Pneumocystis carinii types and various clinical and demographic parameters, we used molecular typing to analyze 93 bronchoalveolar lavage specimens from patients with P. carinii pneumonia (PCP). Multivariate regression analysis revealed an...

  • PCP prophylaxis with use of corticosteroids by neurologists. Kelly, Dearbhla M.; Cronin, Simon // Practical Neurology (BMJ Publishing Group);Apr2014, Vol. 14 Issue 2, p74 

    Pneumocystis jirovecii pneumonia (PCP) is increasingly reported in patients without HIV. Corticosteroids are a major risk factor, with up to 90% of patients receiving corticosteroid treatment prior to the development of PCP. In view of this, many specialties now prescribe PCP prophylaxis to...

  • Trimetrexate glucoronate associated with anti-Kaposi sarcoma effect. Harris, Pamela Jo // AIDS Patient Care & STDs;Oct96, Vol. 10 Issue 5, p280 

    Reports on a patient with AIDS who developed Pneumocystis carinii pneumonia and Kaposi's sarcoma (KS) and was experimentally given trimetrexate glucoronate. Responses to other treatments; Information on Kaposi's sarcoma and treatment for advanced stages; Regression of KS as a result of...

  • Pneumocystis carinii Pneumonia Treated with Pyrimethamine and Sulfadiazine. Kirby, Henry B.; Kenamore, Bruce; Guckian, James C. // Annals of Internal Medicine;Oct71, Vol. 75 Issue 4, p505 

    Provides information on a study on the results of pyrimethamine and sulfadiazine therapy in adults with Pneumocystis carinii. Evaluation of the toxicity of the drugs; Patients of different ethnic backgrounds admitted for Pneumocystis carinii pneumonia; Information on antimicrobial agents.

  • Pulmonary nocardiosis caused by Nocardia exalbida complicating Pneumocystis pneumonia in an HIV-infected patient. Imai, Kentaro; Koibuchi, Tomohiko; Kikuchi, Tadashi; Koga, Michiko; Nakamura, Hitomi; Miura, Toshiyuki; Gonoi, Tohru; Yazawa, Katsukiyo; Iwamoto, Aikichi; Fujii, Takeshi // Journal of Infection & Chemotherapy (Springer Science & Business;Aug2011, Vol. 17 Issue 4, p547 

    A 47-year-old man with optimally controlled type-2 diabetes mellitus and chronic hepatitis B was admitted to a local hospital because of a 1-week history of cough and high-grade fever. He was diagnosed with Pneumocystis pneumonia (PCP) and Klebsiella pneumonia from a chest radiograph and sputum....

  • pentamidine.  // Davis's Drug Guide for Nurses, 10th edition;2007, p935 

    The article presents information on the drug pentamidine for nurses. This antiprotozoal agent is used to treat Pneumocystis carinii pneumonia (PCP). It seems to disrupt DNA or RNA synthesis in protozoa. It has a direct toxic effect on pancreatic islet cells. When a patient takes pentamidine, it...


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics